ABBOTT LABS - N. CHICAGO PLANT | AbbVie | environmental violation | 2011 | EPA | $135,756 |
ACTAVIS,INC. | AbbVie | environmental violation | 2015 | EPA | $30,800 |
AKORN OPERATING COMPANY LLC | Akorn Inc. | environmental violation | 2018 | NJ-ENV | $5,850 |
AKORN OPERATING COMPANY LLC | Akorn Inc. | environmental violation | 2016 | NJ-ENV | $22,800 |
Akorn Operating Company LLC | Akorn Inc. | False Claims Act and related | 2022 | DOJ_CIVIL | $7,900,000 |
AKORN OPERATING COMPANY, LLC | Akorn Inc. | workplace safety or health violation | 2020 | OSHA | $13,653 |
HI TECH PHARMACAL CO., INC. | Akorn Inc. | environmental violation | 2001 | EPA | $20,500 |
CAMBRIDGE MAJOR LABORATORIES INC | Alcami | motor vehicle safety violation | 2006 | FMCSA | $18,560 |
CAMBRIDGE MAJOR LABORATORIES INC | Alcami | motor vehicle safety violation | 2005 | FMCSA | $15,820 |
ALCAMI CORPORATION | Alcami | environmental violation | 2014 | NJ-ENV | $11,900 |
AAIPHARMA SERVICES CORP. | Alcami | workplace safety or health violation | 2013 | OSHA | $11,550 |
ALCAMI CORPORATION | Alcami | workplace safety or health violation | 2018 | OSHA | $6,652 |
Alnylam Pharmaceuticals, Inc. | Alnylam Pharmaceuticals | Medicare Coverage Gap Discount Program violation | 2023 | CMS | $31,959 |
Amgen Inc. | Amgen | off-label or unapproved promotion of medical products | 2012 | FDA | $762,000,000 |
Amgen Inc. | Amgen | False Claims Act and related | 2013 | DOJ_CIVIL | $24,900,000 |
Amgen, Inc. | Amgen | labor relations violation | 2011 | NLRB | $40,000 |
Amgen, Inc. | Amgen | employment discrimination | 2018 | OFCCP | $283,701 |
Amgen, Inc. | Amgen | benefit plan administrator violation | 2017 | private lawsuit-federal | $2,750,000 |
Amgen Inc. | Amgen | False Claims Act and related | 2019 | DOJ_CIVIL | $24,750,000 |
Amgen and Immunex | Amgen | False Claims Act and related | 2008 | AL-AG | $3,500,000 |
Amgen Inc. | Amgen | False Claims Act and related | 2009 | IL-AG | $7,200,000 |
Amgen Inc. | Amgen | False Claims Act and related | 2008 | WI-AG | $2,000,000 |
Amgen Inc. | Amgen | off-label or unapproved promotion of medical products | 2012 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $612,000,000 |
Amgen Inc. | Amgen | off-label or unapproved promotion of medical products | 2015 | MULTI-AG | $71,000,000 |
Amgen, Inc. | Amgen | False Claims Act and related | 2013 | MULTI-AG | $11,000,000 |
Amgen, Inc. | Amgen | False Claims Act and related | 2009 | IA-AG | $357,000 |
Amgen, Inc. | Amgen | False Claims Act and related | 2009 | KY-AG | $2,400,000 |
Immunex Corp. | Amgen | False Claims Act and related | 2009 | IA-AG | $357,000 |
AMGEN INC | Amgen | environmental violation | 2006 | MA-ENV | $11,600 |
AMGEN INC | Amgen | environmental violation | 2002 | MA-ENV | $15,000 |
Amgen Inc. | Amgen | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
Immunex Corporation | Amgen | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
AMGEN SF, LLC | Amgen | workplace safety or health violation | 2013 | OSHA | $5,400 |
Amgen Manufacturing, Limited | Amgen | environmental violation | 2006 | EPA | $20,000 |
Amgen Inc. | Amgen | environmental violation | 2007 | EPA | $24,368 |
Amneal Pharmaceuticals of NY, LLC | Amneal Pharmaceuticals | employment discrimination | 2015 | OFCCP | $99,000 |
Amneal Pharmaceutical, LLC | Amneal Pharmaceuticals | Medicare Coverage Gap Discount Program violation | 2015 | CMS | $5,909 |
Amneal Pharmaceutical, LLC | Amneal Pharmaceuticals | Medicare Coverage Gap Discount Program violation | 2015 | CMS | $9,440 |
Amneal Pharmaceutical, LLC | Amneal Pharmaceuticals | Medicare Coverage Gap Discount Program violation | 2016 | CMS | $10,788 |
Amneal Pharmaceuticals, LLC | Amneal Pharmaceuticals | Medicare Coverage Gap Discount Program violation | 2016 | CMS | $12,367 |
Amneal Pharmaceuticals, LLC | Amneal Pharmaceuticals | Medicare Coverage Gap Discount Program violation | 2019 | CMS | $12,968 |
AMNEAL PHARMACEUTICALS LLC | Amneal Pharmaceuticals | environmental violation | 2020 | NJ-ENV | $10,800 |
AMNEAL PHARMACEUTICALS LLC | Amneal Pharmaceuticals | environmental violation | 2019 | NJ-ENV | $32,400 |
AMNEAL PHARMACEUTICALS | Amneal Pharmaceuticals | environmental violation | 2011 | NJ-ENV | $25,000 |
AMNEAL PHARMACEUTICALS | Amneal Pharmaceuticals | environmental violation | 2007 | NJ-ENV | $9,000 |
Amneal Pharmaceuticals LLC | Amneal Pharmaceuticals | price-fixing or anti-competitive practices | 2019 | private lawsuit-federal | $400,000 |
Impax Laboratories, Inc. | Amneal Pharmaceuticals | price-fixing or anti-competitive practices | 2022 | private lawsuit-federal | $15,000,000 |
Impax Laboratories, Inc. | Amneal Pharmaceuticals | price-fixing or anti-competitive practices | 2022 | private lawsuit-federal | $145,000,000 |
Impax Laboratories, Inc. | Amneal Pharmaceuticals | price-fixing or anti-competitive practices | 2018 | private lawsuit-federal | $20,000,000 |
Impax Laboratories, Inc. | Amneal Pharmaceuticals | price-fixing or anti-competitive practices | 2018 | private lawsuit-federal | $37,500,000 |
IMPAX LABORATORIES, INC | Amneal Pharmaceuticals | workplace safety or health violation | 2004 | OSHA | $18,000 |
AMNEAL PHARMACEUTICALS, LLC. | Amneal Pharmaceuticals | workplace safety or health violation | 2016 | OSHA | $26,725 |
AMNEAL PHARMACEUTICALS, LLC | Amneal Pharmaceuticals | workplace safety or health violation | 2017 | OSHA | $6,791 |
AMNEAL PHARMACEUTICALS | Amneal Pharmaceuticals | workplace safety or health violation | 2022 | OSHA | $6,250 |
AMNEAL PHARMACEUTICALS, LLC | Amneal Pharmaceuticals | workplace safety or health violation | 2022 | OSHA | $8,439 |
Amphastar Pharmaceuticals | Amphastar Pharmaceuticals | wage and hour violation | 2011 | CA-LCO | $25,000 |
Amphastar Pharmaceuticals, Inc. | Amphastar Pharmaceuticals | price-fixing or anti-competitive practices | 2015 | MA-AG | $325,000 |
AMPHASTAR PHARMACEUTICALS INC | Amphastar Pharmaceuticals | workplace safety or health violation | 2002 | OSHA | $18,500 |
Aegerion Pharmaceuticals Inc. | Amryt Pharma | drug or medical equipment safety violation | 2017 | DOJ_CIVIL | $35,000,000 |
Aegerion Pharmaceuticals | Amryt Pharma | investor protection violation | 2017 | SEC | $4,100,000 |
Aegerion Pharmaceuticals Inc. | Amryt Pharma | False Claims Act and related | 2017 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,700,000 |
Amyris, Inc. | Amyris | investor protection violation | 2021 | SEC | $300,000 |
ANIKA THERAPEUTICS INC | Anika Therapeutics | environmental violation | 2003 | MA-ENV | $15,500 |
ANIKA THERAPEUTICS INC. | Anika Therapeutics | workplace safety or health violation | 2013 | OSHA | $5,800 |
Apotex | Apotex Corp. | False Claims Act and related | 2013 | LA-AG | $4,000,000 |
Apotex Corp. | Apotex Corp. | price-fixing or anti-competitive practices | 2020 | DOJ_ANTITRUST | $24,100,000 |
Apotex Corporation | Apotex Corp. | False Claims Act and related | 2021 | DOJ_CIVIL | $49,000,000 |
OSI Pharmaceuticals LLC | Astellas Pharma | False Claims Act and related | 2016 | DOJ_CIVIL | $67,000,000 |
Astellas Pharma US Inc. | Astellas Pharma | False Claims Act and related | 2014 | DOJ_CIVIL | $7,300,000 |
Astellas Pharma US Inc. | Astellas Pharma | False Claims Act and related | 2019 | DOJ_CIVIL | $100,000,000 |
Astellas | Astellas Pharma | False Claims Act and related | 2013 | LA-AG | $1,130,000 |
Astellas Pharma US Inc. | Astellas Pharma | False Claims Act and related | 2014 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $3,100,000 |
OSI Pharmaceuticals LLC | Astellas Pharma | False Claims Act and related | 2016 | DOJ_CIVIL | $33,500,000 |
OSI Pharmaceuticals LLC | Astellas Pharma | False Claims Act and related | 2016 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,200,000 |
Astellas Pharma US, Inc. | Astellas Pharma | campaign finance violation | 2022 | FEC | $7,500 |
Astellas Pharma US, Inc. | Astellas Pharma | price-fixing or anti-competitive practices | 2015 | private lawsuit-federal | $98,000,000 |
Astellas Pharma US, Inc. | Astellas Pharma | price-fixing or anti-competitive practices | 2016 | private lawsuit-federal | $13,250,000 |
Fujisawa Healthcare, Inc. | Astellas Pharma | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
AstraZeneca LP | AstraZeneca | off-label or unapproved promotion of medical products | 2010 | FDA | $520,000,000 |
AstraZeneca LP | AstraZeneca | False Claims Act and related | 2015 | DOJ_CIVIL | $7,900,000 |
AstraZeneca LP | AstraZeneca | False Claims Act and related | 2015 | DOJ_CIVIL | $46,500,000 |
AstraZeneca Pharmaceuticals | AstraZeneca | False Claims Act and related | 2009 | DOJ_CIVIL | $2,600,000 |
AstraZeneca Pharmaceuticals LP | AstraZeneca | False Claims Act and related | 2003 | DOJ_CIVIL | $354,900,000 |
AstraZeneca PLC | AstraZeneca | kickbacks and bribery | 2016 | SEC | $5,522,000 |
AstraZeneca | AstraZeneca | employment discrimination | 2011 | OFCCP | $250,000 |
AstraZeneca | AstraZeneca | employment discrimination | 2008 | private lawsuit-state | $350,000 |
Alexion Pharmaceuticals Inc. | AstraZeneca | False Claims Act and related | 2019 | DOJ_CIVIL | $13,000,000 |
AstraZeneca | AstraZeneca | False Claims Act and related | 2004 | FL-AG | $807,826 |
AstraZeneca | AstraZeneca | off-label or unapproved promotion of medical products | 2013 | KY-AG | $5,500,000 |
AstraZeneca | AstraZeneca | consumer protection violation | 2010 | KY-AG | $5,391,000 |
AstraZeneca | AstraZeneca | False Claims Act and related | 2009 | KY-AG | $14,700,000 |
AstraZeneca | AstraZeneca | False Claims Act and related | 2018 | TX-AG | $110,000,000 |
AstraZeneca LP | AstraZeneca | False Claims Act and related | 2015 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $46,500,000 |
AstraZeneca Pharmaceuticals | AstraZeneca | off-label or unapproved promotion of medical products | 2011 | MULTI-AG | $68,500,000 |
AstraZeneca Pharmaceuticals LP | AstraZeneca | False Claims Act and related | 2003 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $24,900,000 |
AstraZeneca Pharmaceuticals LP | AstraZeneca | False Claims Act and related | 2009 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,600,000 |
AstraZeneca Pharmaceuticals LP | AstraZeneca | off-label or unapproved promotion of medical products | 2010 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $218,092,993 |
AstraZeneca Pharmaceuticals LP and AstraZeneca LP | AstraZeneca | False Claims Act and related | 2011 | ID-AG | $2,500,000 |
AstraZeneca Pharmaceuticals, LP | AstraZeneca | False Claims Act and related | 2010 | HI-AG | $3,333,333 |
Alexion Pharmaceuticals Inc. | AstraZeneca | Foreign Corrupt Practices Act | 2020 | SEC | $21,000,000 |
AstraZeneca | AstraZeneca | employment discrimination | 2021 | OFCCP | $560,000 |